Jpmorgan Chase & CO Terns Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 59,536 shares of TERN stock, worth $342,332. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,536
Previous 153,080 61.11%
Holding current value
$342,332
Previous $1.04 Million 52.4%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
SELL
$6.49 - $10.8 $607,100 - $1.01 Million
-93,544 Reduced 61.11%
59,536 $496,000
Q3 2024

Nov 08, 2024
SELL
$6.49 - $10.8 $607,100 - $1.01 Million
-93,544 Reduced 61.11%
59,536 $496,000
Q2 2024

Dec 26, 2024
BUY
$4.54 - $8.2 $424,689 - $767,060
93,544 Added 157.12%
153,080 $1.04 Million
Q2 2024

Aug 12, 2024
SELL
$4.54 - $8.2 $1.22 Million - $2.2 Million
-268,557 Reduced 63.69%
153,080 $1.04 Million
Q1 2024

Dec 26, 2024
BUY
$4.86 - $8.19 $1.76 Million - $2.97 Million
362,101 Added 608.21%
421,637 $2.77 Million
Q1 2024

May 10, 2024
BUY
$4.86 - $8.19 $988,698 - $1.67 Million
203,436 Added 93.23%
421,637 $2.77 Million
Q4 2023

Dec 26, 2024
BUY
$3.37 - $6.86 $534,701 - $1.09 Million
158,665 Added 266.5%
218,201 $1.42 Million
Q4 2023

Feb 12, 2024
SELL
$3.37 - $6.86 $218,827 - $445,447
-64,934 Reduced 22.93%
218,201 $1.42 Million
Q3 2023

Nov 14, 2023
SELL
$4.7 - $8.55 $462,856 - $842,004
-98,480 Reduced 25.81%
283,135 $1.42 Million
Q2 2023

Aug 11, 2023
SELL
$7.35 - $13.29 $1.84 Million - $3.32 Million
-250,131 Reduced 39.59%
381,615 $3.34 Million
Q1 2023

May 11, 2023
SELL
$7.91 - $12.0 $4.55 Million - $6.9 Million
-575,405 Reduced 47.67%
631,746 $7.48 Million
Q4 2022

Feb 13, 2023
BUY
$4.62 - $10.18 $1.33 Million - $2.93 Million
288,109 Added 31.35%
1,207,151 $12.3 Million
Q3 2022

Nov 14, 2022
BUY
$1.87 - $6.42 $1.72 Million - $5.89 Million
918,079 Added 95335.31%
919,042 $5.41 Million
Q2 2022

Aug 11, 2022
SELL
$1.5 - $3.0 $12,606 - $25,212
-8,404 Reduced 89.72%
963 $2,000
Q1 2022

May 11, 2022
BUY
$2.83 - $6.7 $5,442 - $12,884
1,923 Added 25.83%
9,367 $28,000
Q4 2021

Feb 10, 2022
BUY
$5.65 - $10.73 $12,373 - $23,498
2,190 Added 41.68%
7,444 $52,000
Q3 2021

Nov 12, 2021
BUY
$7.22 - $13.46 $37,933 - $70,718
5,254 New
5,254 $55,000

Others Institutions Holding TERN

# of Institutions
167
Shares Held
78.3M
Call Options Held
580K
Put Options Held
454K
View Full List

About Terns Pharmaceuticals, Inc.

TERN Quotes by TradingView
  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $216M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email